P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO-CONTROLLED RANDOMIZED CROSS-OVER CLINICAL TRIAL

P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO-CONTROLLED RANDOMIZED CROSS-OVER CLINICAL TRIAL

Bibliographic Details
Main Authors:	A. Van Vuren, J. Kerkhoffs, S. Schols, A. Rijneveld, E. Nur, D. Peereboom, Y. Gandon, P. Welsing, R. van Wijk, R. Schutgens, W. van Solinge, J. Marx, T. Leiner, B. Biemond, E. van Beers
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000849120.09870.c6

Similar Items

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
by: Annelies J. van Vuren, et al.
Published: (2021-09-01)

A Unique Monocyte Transcriptome Discriminates Sickle Cell Disease From Other Hereditary Hemolytic Anemias and Shows the Particular Importance of Lipid and Interferon Signaling
by: Annelies J. van Vuren, et al.
Published: (2021-03-01)

Red blood cell vesiculation in hereditary hemolytic anemia
by: Amr eAlaarg, et al.
Published: (2013-12-01)

Hepatocellular Carcinoma in Hereditary Hemochromatosis
by: Paul C Adams
Published: (1993-01-01)

Inflammation can increase hepcidin in HFE‐hereditary hemochromatosis
by: Wenke Moris, et al.
Published: (2021-05-01)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: VAN DIJK M., et al.
Published: (2022-08-01)

2039 T2* CMR in hereditary hemochromatosis
by: O'Hanlon Rory, et al.
Published: (2008-10-01)

Overview of Ankle Arthropathy in Hereditary Hemochromatosis
by: Sara Calori, et al.
Published: (2023-08-01)

Hereditary hemochromatosis: An opportunity for gene therapy
by: FERNANDO EZQUER, et al.
Published: (2006-01-01)

Hypogonadotropic hypogonadism in men with hereditary hemochromatosis
by: Rabih El Osta, et al.
Published: (2017-07-01)

Bull's eye maculopathy associated with hereditary hemochromatosis
by: Kellyn N. Bellsmith, et al.
Published: (2020-06-01)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
by: Myrthe van Dijk, et al.
Published: (2023-08-01)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients
by: Annelies van Vuren, et al.
Published: (2019-08-01)

Severe osteoporosis as atypical presentation of hereditary hemochromatosis
by: Georgiana Cristina Taujan, et al.
Published: (2022-10-01)

Therapeutic Erythrocytapheresis in the Initial Treatment of Hereditary Hemochromatosis
by: Vít Řeháček, et al.
Published: (2012-01-01)

Paraoxonase-1 status in patients with hereditary hemochromatosis
by: Nicola Martinelli, et al.
Published: (2013-05-01)

Hereditary Hemochromatosis: Genetics, Pathogenesis, and Clinical Management
by: Jacob Alexander, et al.
Published: (2005-10-01)

Novel observations in hereditary hemochromatosis: potential implications for clinical strategies
by: Dorine W. Swinkels, et al.
Published: (2011-04-01)

Hereditary Hemochromatosis Unmasked by Yersiniosis: Report of Three Cases
by: Karam Karam, et al.
Published: (2025-01-01)

Prognostic Factors and Survival in Patients with Hereditary Hemochromatosis and Cirrhosis
by: Melanie D Beaton, et al.
Published: (2006-01-01)

Screening for Hereditary Hemochromatosis in Newly Referred Diabetes Mellitus
by: Michael Lockhart, et al.
Published: (2023-12-01)

Hereditary hemochromatosis and JAK2‐positive polycythemia vera
by: Ahmed Radwan, et al.
Published: (2021-10-01)

Idiopathic brain calcification in a patient with hereditary hemochromatosis
by: Stefania Scarlini, et al.
Published: (2020-03-01)

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: M. J. van Dijk, et al.
Published: (2022-06-01)

Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis
by: Höblinger A, et al.
Published: (2009-04-01)

P-19 SPLENIC IRON OVERLOAD IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS
by: Maria Florencia Yamasato, et al.
Published: (2023-03-01)

Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China
by: Liyan Wu, et al.
Published: (2021-09-01)

Metabolic Fingerprint in Hereditary Spherocytosis Correlates With Red Blood Cell Characteristics and Clinical Severity
by: Birgit van Dooijeweert, et al.
Published: (2021-07-01)

A rare case of porphyria cutanea tarda in a patient with a homozygous hereditary hemochromatosis gene H63D mutation in the setting of hereditary hemochromatosis
by: Jonathan Banta, MD, et al.
Published: (2024-08-01)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: M.J. van Dijk, et al.
Published: (2023-04-01)

Assessment of Drusen and other retinal degenerative changes in patients with hereditary hemochromatosis
by: Menghini, M, et al.
Published: (2018)

TSAT-Urated Insights: Clarifying the Complexities of Hereditary Hemochromatosis and Its Guidelines
by: Chiara Marcon, et al.
Published: (2024-12-01)

Pathogenesis, Diagnosis, and Clinical Implications of Hereditary Hemochromatosis—The Cardiological Point of View
by: Ludmiła Daniłowicz-Szymanowicz, et al.
Published: (2021-07-01)

Visão atual da hemocromatose hereditária Current approach to hereditary hemochromatosis
by: Rodolfo Delfini Cançado, et al.
Published: (2010-01-01)

Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis
by: Jessica Seeßle, et al.
Published: (2020-07-01)

Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis
by: Wei Zhang, et al.
Published: (2022-06-01)

Hereditary Hemochromatosis <it>(HFE) </it>genotypes in heart failure: Relation to etiology and prognosis
by: Torp-Pedersen Christian, et al.
Published: (2010-07-01)

Infectious Mononucleosis Causing Acute Liver Failure and Hemolytic Anemia in a Patient with Underlying Hereditary Hemochromatosis
by: Mark Forsberg, et al.
Published: (2020-09-01)

DISCOVERY OF MORE CHANGING LOOK EVENTS IN NGC 1566
by: V. L. Oknyansky, et al.
Published: (2019-11-01)

Low ceruloplasmin levels exacerbate retinal degeneration in a hereditary hemochromatosis model
by: Brandon D. Anderson, et al.
Published: (2023-07-01)